Research & Literature

Multiple liver lesions in a patient with Budd-Chiari syndrome secondary to polycythemia vera.

Putra J, Toor A, Noce TA, et al.

Annals of hepatology 2015; (14(4)):547-9.

Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment.

De Stefano V, Qi X, Betti S, Rossi E

Thrombosis and haemostasis 2016; (115(2)):240-9 doi:10.1160/TH15-04-0326.

Budd-Chiari Syndrome in Young Chinese: Clinical Characteristics, Etiology and Outcome of Recanalization from a Single Center.

Zhou WJ, Cui YF, Zu MH, et al.

Cardiovascular and interventional radiology 2016; (39(4)):557-65 doi:10.1007/s00270-016-1295-4.

Comparison of Long-Term Outcomes of Endovascular Management for Membranous and Segmental Inferior Vena Cava Obstruction in Patients With Primary Budd-Chiari Syndrome.

Huang Q, Shen B, Zhang Q, et al.

Circulation. Cardiovascular interventions 2016; (9(3)):e003104.

Budd- Chiari Syndrome as an Initial Manifestation of Systemic Lupus Erythematosus.

Pandiaraja J, Sathyaseelan A

Journal of clinical and diagnostic research : JCDR 2016; (10(4)):OD01-2 doi:10.7860/JCDR/2016/16623.7532.

Long-term outcomes following percutaneous hepatic vein recanalization for Budd-Chiari syndrome.

Tripathi D, Sunderraj L, Vemala V, et al.

Liver international : official journal of the International Association for the Study of the Liver 2017; (37(1)):111-120 doi:10.1111/liv.13180.

Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd-Chiari syndrome.

Sakr M, Abdelhakam SM, Dabbous H, et al.

Liver international : official journal of the International Association for the Study of the Liver 2017; (37(3)):415-422 doi:10.1111/liv.13219.

Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?

Lamy M, Palazzo P, Agius P, et al.

Cerebrovascular diseases (Basel, Switzerland) 2017; (44(3-4)):97-104 doi:10.1159/000471891.

Early radiological intervention and haematology screening is associated with excellent outcomes in Budd-Chiari syndrome.

Mo A, Testro A, French J, et al.

Internal medicine journal 2017; (47(12)):1361-1367 doi:10.1111/imj.13544.

A single-center retrospective study: Clinical features of different types of Budd-Chiari syndrome in Chinese patients in the Hubei area.

Li G, Huang Y, Tang S, et al.

Vascular 2018; (26(1)):80-89 doi:10.1177/1708538117718638.

Budd-Chiari Syndrome.

Grus T, Lambert L, Grusová G, et al.

Prague medical report 2017; (118(2-3)):69-80 doi:10.14712/23362936.2017.6.

Living donor liver transplantation for adult Budd Chiari syndrome - Resection without replacement of retrohepatic IVC: A case report.

Sabra TA, Okajima H, Tajima T, et al.

International journal of surgery case reports 2018; (42()):50-54 doi:10.1016/j.ijscr.2017.11.050.

Diagnosis of Budd-Chiari syndrome.

Van Wettere M, Bruno O, Rautou PE, et al.

Abdominal radiology (New York) 2018; (43(8)):1896-1907 doi:10.1007/s00261-017-1447-2.

Timing of Transjugular Intrahepatic Portosystemic Shunt for Budd-Chiari Syndrome: An Italian Hepatologist's Perspective.

Mancuso A

Journal of translational internal medicine 2017; (5(4)):194-199 doi:10.1515/jtim-2017-0033.

Benign and malignant hepatocellular lesions in patients with vascular liver diseases.

Vilgrain V, Paradis V, Van Wettere M, et al.

Abdominal radiology (New York) 2018; (43(8)):1968-1977 doi:10.1007/s00261-018-1502-7.

The relationship between the levels and function of endothelial progenitor cells and factor V Leiden and protein C deficiency in patients with primary Budd-Chiari syndrome.

Guan ZY, Yu CW, Song T, Gao Y

European review for medical and pharmacological sciences 2018; (22(9)):2742-2750 doi:10.26355/eurrev_201805_14971.

Detecting CALR Mutations in Splanchnic Vein Thrombosis: Who and How?

Langabeer SE

Journal of translational internal medicine 2018; (6(2)):55-57 doi:10.2478/jtim-2018-0015.

Budd-Chiari syndrome: imaging review.

Bansal V, Gupta P, Sinha S, et al.

The British journal of radiology 2018; (91(1092)):20180441 doi:10.1259/bjr.20180441.

Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome.

Dajti E, Ravaioli F, Colecchia A, et al.

Canadian journal of gastroenterology & hepatology 2019; (2019()):1673197 doi:10.1155/2019/1673197.

Long Term Survival of Patients Undergoing TIPS in Budd-Chiari Syndrome.

Sonavane AD, Amarapurkar DN, Rathod KR, Punamiya SJ

Journal of clinical and experimental hepatology 2019; (9(1)):56-61 doi:10.1016/j.jceh.2018.02.008.

Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome.

Khan F, Armstrong MJ, Mehrzad H, et al.

Alimentary pharmacology & therapeutics 2019; (49(7)):840-863 doi:10.1111/apt.15149.

Milestones in the discovery of Budd-Chiari syndrome.

Zanetto A, Pellone M, Senzolo M

Liver international : official journal of the International Association for the Study of the Liver 2019; (39(7)):1180-1185 doi:10.1111/liv.14088.

Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trial.

Wang Q, Li K, He C, et al.

The lancet. Gastroenterology & hepatology 2019; (4(9)):686-697 doi:10.1016/S2468-1253(19)30177-3.

Budd-Chiari Syndrome and hepatic regenerative nodules: Magnetic resonance findings with emphasis of hepatobiliary phase.

Mamone G, Carollo V, Di Piazza A, et al.

European journal of radiology 2019; (117()):15-25 doi:10.1016/j.ejrad.2019.05.015.

Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging.

Zech CJ, Ba-Ssalamah A, Berg T, et al.

European radiology 2020; (30(1)):370-382 doi:10.1007/s00330-019-06369-4.

Dabigatran as an oral anticoagulant in patients with Budd-Chiari syndrome post-percutaneous endovascular intervention.

Sharma S, Kumar R, Rout G, et al.

Journal of gastroenterology and hepatology 2020; (35(4)):654-662 doi:10.1111/jgh.14843.

Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature.

Hung ML, Lee EW

Clinics in liver disease 2019; (23(4)):737-754 doi:10.1016/j.cld.2019.07.004.

Hepatic amyloidosis leading to hepatic venular occlusive disease and Budd-Chiari syndrome: A case report.

Li TT, Wu YF, Liu FQ, He FL

World journal of clinical cases 2019; (7(20)):3282-3288 doi:10.12998/wjcc.v7.i20.3282.

Pediatric Hepatic Venous Outflow Tract Obstruction: Experience from a Transplant Center.

Malik I, Bhatia V, Kumar K, et al.

Indian pediatrics 2019; (56(11)):965-967.

Acute-on-Chronic Liver Failure in Budd-Chiari Syndrome: Profile and Predictors of Outcome.

Shalimar , Sharma S, Gamanagatti SR, et al.

Digestive diseases and sciences 2020; (65(9)):2719-2729 doi:10.1007/s10620-019-06005-7.

Venous thrombosis of the liver: current and emerging concepts in management.

Naymagon L

Translational research : the journal of laboratory and clinical medicine 2020; (225()):54-69 doi:10.1016/j.trsl.2020.04.012.

Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.

Joo I, Kim SY, Kang TW, et al.

Radiology 2020; (296(2)):335-345 doi:10.1148/radiol.2020192275.

Small hepatic veins Budd-Chiari syndrome and paroxysmal nocturnal hemoglobinuria - The association of two rare entities: a case report.

Gioia S, De Santis E, Cerbelli B, et al.

Pathologica 2020; (112(2)):102-104 doi:10.32074/1591-951X-4-20.

Budd-Chiari syndrome diagnosed with pregnancy in a patient with inherited thrombophilia.

Elkhateb IT, Mousa A, Hashem A

BMJ case reports 2021; (14(1)) doi:10.1136/bcr-2020-237761.

Clinical outcomes of large diameter balloon angioplasty for Budd-Chiari syndrome with inferior vena cava involvement.

Bi Y, Yi M, Han X, Ren J

Journal of vascular surgery. Venous and lymphatic disorders 2021; (9(5)):1168-1177 doi:10.1016/j.jvsv.2021.01.006.

A Nationwide Analysis of Budd-Chiari Syndrome in the United States.

Alukal JJ, Zhang T, Thuluvath PJ

Journal of clinical and experimental hepatology 2021; (11(2)):181-187 doi:10.1016/j.jceh.2020.08.005.

Utility of Hepatic 2D Shear-Wave Elastography in Monitoring Response to Image-Guided Intervention in Children With Chronic Budd-Chiari Syndrome: A Prospective Study.

Dohare N, Madhusudhan KS, Malik R, et al.

AJR. American journal of roentgenology 2022; (218(3)):534-543 doi:10.2214/AJR.21.26547.

Single-center study: evaluation of sonography in Budd-Chiari syndrome.

Hoffmann T, Voigtländer H, Fröhlich E, et al.

Zeitschrift fur Gastroenterologie 2022; (60(7)):1111-1117 doi:10.1055/a-1550-3141.

Clinical Utility of Transient Elastography in the Management of Patients with Budd-Chiari Syndrome Undergoing Endovascular Intervention.

Anand A, Biswas S, Vaishnav M, et al.

Journal of vascular and interventional radiology : JVIR 2022; (33(3)):268-277.e3 doi:10.1016/j.jvir.2021.11.003.

Primary Myelofibrosis in the Prefibrotic Stage Presenting as Portal, Splenic, and Superior Mesenteric Vein Thrombosis: A Case Report and Review of the Literature.

Dias E, Liberal R, Costa-Moreira P, et al.

GE Portuguese journal of gastroenterology 2022; (29(2)):125-131 doi:10.1159/000514658.

Percutaneous transluminal angioplasty for symptomatic hepatic vein-type Budd-Chiari syndrome: feasibility and long-term outcomes.

Elkilany A, Alwarraky M, Denecke T, Geisel D

Scientific reports 2022; (12(1)):14095 doi:10.1038/s41598-022-16818-8.

Large Regenerative Nodules and Focal Nodular Hyperplasia-Like Lesions: Definition, Pathogenesis, and Imaging Findings.

Nolan PE, Catania R, Vendrami CL, et al.

Radiologic clinics of North America 2022; (60(5)):795-808 doi:10.1016/j.rcl.2022.05.004.

Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis.

Li KS, Guo S, Chen YX, Zhang ZL

Frontiers in oncology 2022; (12()):1075685 doi:10.3389/fonc.2022.1075685.

Management of splanchnic vein thrombosis.

Elkrief L, Payancé A, Plessier A, et al.

JHEP reports : innovation in hepatology 2023; (5(4)):100667 doi:10.1016/j.jhepr.2022.100667.

Histopathology of Budd-Chiari Syndrome.

Quaglia A

Diagnostics (Basel, Switzerland) 2023; (13(15)) doi:10.3390/diagnostics13152487.

Budd-Chiari Syndrome as an Initial Presentation of Systemic Lupus Erythematosus Associated with Antiphospholipid Syndrome: A Case Report with Review of the Literature.

Solela G, Daba M

Open access rheumatology : research and reviews 2023; (15()):139-143 doi:10.2147/OARRR.S425535.

Budd-Chiari Syndrome following COVID-19 infection: a case report.

Sawaqed SS, Urabi HM, Al-Thnaibat MH, et al.

Annals of medicine and surgery (2012) 2023; (85(9)):4570-4574 doi:10.1097/MS9.0000000000001078.

A case of acute liver failure caused by Budd-Chiari syndrome salvaged by brain-dead donor liver transplantation.

Kimura K, Osaki A, Hirata Y, et al.

Clinical journal of gastroenterology 2024; (17(1)):84-92 doi:10.1007/s12328-023-01863-1.

Recent outcomes of liver transplantation for Budd-Chiari syndrome: A study of the European Liver Transplant Registry (ELTR) and affiliated centers.

Dongelmans E, Erler N, Adam R, et al.

Hepatology (Baltimore, Md.) 2024; (80(1)):136-151 doi:10.1097/HEP.0000000000000778.

The Role of Transjugular Intrahepatic Portosystemic Shunt for the Management of Ascites in Patients with Decompensated Cirrhosis.

Iannone G, Pompili E, De Venuto C, et al.

Journal of clinical medicine 2024; (13(5)) doi:10.3390/jcm13051349.

Acute upper gastrointestinal bleeding due to portal hypertension in a patient with primary myelofibrosis: A case report.

Chen Y, Kong BB, Yin H, et al.

World journal of clinical cases 2024; (12(15)):2621-2626 doi:10.12998/wjcc.v12.i15.2621.

TEN-YEAR OUTCOMES OF TIPS FOR BUDD-CHIARI SYNDROME: SYSTEMATIC REVIEW AND META-ANALYSIS.

Moreno MOA, Paz CLDSL, Dezan MGF, et al.

Arquivos de gastroenterologia 2024; (61()):e23171 doi:10.1590/S0004-2803.24612023-171.

A Clinical Case of Timely Diagnosis and Successful Treatment of Budd-Chiari Syndrome With Fulminant Cytolysis in the Setting of a First-time Diagnosed Myeloproliferative Disease.

Husieva SA, Osyodlo GV, Husiev AV, Savichan KV

Military medicine 2025; (190(5-6)):1292-1299 doi:10.1093/milmed/usae331.

Imaging findings of Budd-Chiari syndrome caused by intravenous leiomyomatosis: a case report.

Wang Y, Dong Y, Tian X, et al.

Frontiers in medicine 2024; (11()):1422652 doi:10.3389/fmed.2024.1422652.

Hepatocellular carcinoma as a complication of chronic Budd-Chiari syndrome (BCS) in a child.

Sharma D, Khera S, Saravagi G, Dhaman PK

BMJ case reports 2024; (17(8)) doi:10.1136/bcr-2024-261764.

Direct Oral Anticoagulants in Budd-Chiari Syndrome.

Thapa SB, Souza GR, Paravathaneni M, et al.

European journal of haematology 2025; (114(3)):566-572 doi:10.1111/ejh.14363.

Imaging in Vascular Liver Diseases.

Rosselli M, Popescu A, Bende F, et al.

Medicina (Kaunas, Lithuania) 2024; (60(12)) doi:10.3390/medicina60121955.

Comparison of direct intrahepatic portosystemic shunt and other major radiological interventions in patients with Budd-Chiari syndrome.

Malakar S, Shah N, Hoda US, et al.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2025; (44(5)):708-718 doi:10.1007/s12664-024-01733-9.

A case of Budd-Chiari syndrome with acute venous thrombosis and liver failure: highlighting the importance of early intervention and anticoagulation therapy.

Otoyama Y, Kimura M, Nishikawa K, et al.

Clinical journal of gastroenterology 2025; (18(4)):689-694 doi:10.1007/s12328-025-02135-w.

A Rare Case of Budd-Chiari Syndrome in a Young Female.

Chacko J, Haward R, Shah NA, et al.

Clinical case reports 2025; (13(5)):e70478 doi:10.1002/ccr3.70478.

Long-term outcomes of transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome: A multicenter study.

Swaroop S, Janeela AM, Valsan A, et al.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2025; (57(10)):1958-1964 doi:10.1016/j.dld.2025.06.026.

Budd-Chiari Syndrome and Pregnancy-A Review.

Giri S, Malakar S, Sahoo S, et al.

Journal of clinical and experimental hepatology 2026; (16(1)):103176 doi:10.1016/j.jceh.2025.103176.

Efficacy and Safety of Direct Oral Anticoagulants in Budd-Chiari Syndrome After Percutaneous Recanalization.

Wu C, Shen Y, Gao Z, et al.

Hepatology research : the official journal of the Japan Society of Hepatology 2026; (56(2)):195-203 doi:10.1111/hepr.70057.

Primary Budd-Chiari syndrome due to lupus anticoagulant positive antiphospholipid syndrome.

J U S, Premkumar S, Sivaprakasam E

BMJ case reports 2025; (18(10)) doi:10.1136/bcr-2025-267045.

Common features of Budd Chiari syndrome in Sudanese population: a computed tomography-based review and descriptive analysis.

Ali Bakry AH, Bashir A, Almuqbil N, et al.

Frontiers in medicine 2025; (12()):1552366 doi:10.3389/fmed.2025.1552366.

Early Endovascular Intervention in Combination with Medical Therapy versus Medical Therapy Alone in the Initial Management of Patients with Primary Budd-Chiari Syndrome: A Randomized Controlled Trial.

Biswas S, Swaroop S, Mehta S, et al.

Journal of vascular and interventional radiology : JVIR 2026; (37(3)):107967 doi:10.1016/j.jvir.2025.107967.

Multidisciplinary collaboration successfully treated Budd Chiari syndrome complicated with hepatocellular carcinoma rupture and bleeding: A case report.

Liao L, Qiu Y, Gong X

Medicine 2025; (104(51)):e46748 doi:10.1097/MD.0000000000046748.

Ultrasound Characteristics of Budd-Chiari Syndrome: A Multicenter Analysis.

Daza J, Wiest I, Cui XW, et al.

Digestive diseases (Basel, Switzerland) 2026; (44(2)):192-205 doi:10.1159/000549007.